BALTIMORE, April 16, 2025 (GLOBE NEWSWIRE) -- BC3 Technologies, a Baltimore-based, minority-owned company revolutionizing emergency medical response and trauma care, has received a U.S. patent that ...
Add The Drive (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results While ...
SEAL Hemostatic Wound Spray from BC3 Technologies is designed to meet the challenges of arterial bleeding. When sprayed on a wound and upon contact with blood or exudate, SEAL quickly forms a strong ...
(MENAFN- GlobeNewsWire - Nasdaq) -- FDA-Cleared Aerosolized Chitosan Hemostatic Agent Receives Patent for its Innovative Material and Method -- BALTIMORE, April 16, 2025 (GLOBE NEWSWIRE) -- BC3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results